So far, five biosimilars that reference Eylea 2 mg have been approved by the FDA. Alvotech/Teva expect to regulatory approval for its biosimilar to be completed in the fourth quarter of 2025.

In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...

First-term state Rep. Katrina Pierson (HD-33) late last week announced her appointment to the House public health committee ...

Both the Silverado 1500 and the Silverado HD have the impressive High Country and LTZ trims available for buyers. However, ...

In today’s fast-paced world, safety on the road is paramount. Whether you’re commuting to work or embarking on a family road trip, the need for vigilance while driving has never been greater. This is ...

HD Korea Shipbuilding & Offshore Engineering (HD KSOE), an intermediary holding company for HD Hyundai’s shipbuilding sector has obtained Approval in Principle (AIP) from the American Bureau of ...

The company plans to build a marine nuclear demo facility at its Future Technology Test Centre in Yongin, South Korea.

In today’s fast-paced world, ensuring safety on the road has become more crucial than ever before. With rising incidents of accidents and vehicle thefts, having a reliable dash cam is no longer a ...

HD Korea Shipbuilding & Offshore Engineering (KSOE), a major South Korean shipbuilder, introduced a nuclear-powered ...